Anchorage Capital Group, L.L.C.
Follow13F filer, CIK 1300714, NEW YORK, NY
Anchorage Capital Group, L.L.C. reported $381,993,699 across 7 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000905148-24-003149
- Period
- 2024-09-30
- Reported value
- $382M
- Holdings
- 7
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| DNAnew | +1,746,363 | $14.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS INCexited | -69,854,593 | -$23.4M |
| DNABWexited | -50,000 | -$1.41K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000905148-24-003149, largest first. % of portfolio is the value over $381,993,699, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| FYBRFRONTIER COMMUNICATIONS PARE | 5,123,545 | $182M | 47.66% | 0 | Timeline | ||
| SSENTINELONE INC | 4,937,053 | $118M | 30.92% | 0 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 4,832,642 | $55.8M | 14.6% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 1,746,363 | $14.2M | 3.73% | new | Timeline | ||
| AMBPARDAGH METAL PACKAGING S A | 1,250,000 | $4.71M | 1.23% | 0 | Timeline | ||
| ARDAGH METAL PACKAGING S AARDAGH METAL PACKAGING S A | 1,245,385 | $52.2K | 0.01% | 0 |
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| THE REALREAL INCTHE REALREAL INC CNV | principal | 15,097,000 | $7.09M | 0 |
Sold out in Q3 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| GINKGO BIOWORKS HOLDINGS INCGINKGO BIOWORKS HOLDINGS INC | 69,854,593 | $23.4M | shares |
| DNABWGINKGO BIOWORKS HLDGS INC WT E | 50,000 | $1.41K | shares |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000905148-24-003149 | base | 2024-11-14 | acceptance time not in the bulk data set |